Tekla Healthcare Investors and Tekla Life Sciences Investors

Represented Tekla Healthcare Investors and Tekla Life Sciences Investors, closed-end funds focused on investments in public and private healthcare companies, in connection with their investments in the Series E Preferred Stock financing of Sutro Biopharma,  a clinical stage drug discovery company creating protein therapeutics for oncology and autoimmune disorders.